Andrea Grant
Keine laufenden Positionen mehr
Karriereverlauf von Andrea Grant
Ehemalige bekannte Positionen von Andrea Grant
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 16.11.2012 | 01.04.2014 |
| Vorstandsvorsitzender | 28.12.2011 | 01.04.2014 | |
| Investor Relations Kontakt | 28.12.2011 | 01.04.2014 | |
| Public Communications Contact | 28.12.2011 | 01.04.2014 | |
Galapagos Genomics NV
 Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery. Galapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma. | Corporate Officer/Principal | - | 02.05.2008 |
Diatranz Otsuka Ltd.
 Diatranz Otsuka Ltd. Pharmaceuticals: MajorHealth Technology Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand. | Vorstandsvorsitzender | 01.04.2014 | - |
Ausbildung von Andrea Grant
| University of Cambridge | Doctorate Degree |
Statistik
International
| Neuseeland | 3 |
| Belgien | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Galapagos Genomics NV
Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery. Galapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma. | Health Technology |
Diatranz Otsuka Ltd.
Diatranz Otsuka Ltd. Pharmaceuticals: MajorHealth Technology Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand. | Health Technology |
- Börse
- Insiders
- Andrea Grant
- Erfahrung